{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T15:28:21Z","timestamp":1773934101444,"version":"3.50.1"},"reference-count":99,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004955","name":"Austrian Research Promotion Agency","doi-asserted-by":"publisher","award":["892424"],"award-info":[{"award-number":["892424"]}],"id":[{"id":"10.13039\/501100004955","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018774","name":"Bundesministerium f\u00fcr Klimaschutz, Umwelt, Energie, Mobilit\u00e4t, Innovation und Technologie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018774","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100031306","name":"Bundesministerium f\u00fcr Arbeit und Wirtschaft","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100031306","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.ejpb.2025.114964","type":"journal-article","created":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T17:07:31Z","timestamp":1765818451000},"page":"114964","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["3D-printing of lipid formulations: Going slow in a fast-paced field"],"prefix":"10.1016","volume":"219","author":[{"given":"Moaaz","family":"Abdelhamid","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dalip","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5606-3607","authenticated-orcid":false,"given":"Martin","family":"Spoerk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2829-4074","authenticated-orcid":false,"given":"Sharareh","family":"Salar-Behzadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejpb.2025.114964_b0005","article-title":"Lipid-based Drug delivery Systems","volume":"2014","author":"Shrestha","year":"2014","journal-title":"J Pharm (cairo)"},{"key":"10.1016\/j.ejpb.2025.114964_b0010","unstructured":"IQ4I Research & Consultancy, World Pharmaceutical Excipients Reports Collection, Bangalore, 2019."},{"key":"10.1016\/j.ejpb.2025.114964_b0015","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.ijpharm.2018.12.080","article-title":"Lipids and polymers in pharmaceutical technology: Lifelong companions","volume":"558","author":"Siepmann","year":"2019","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2025.114964_b0020","doi-asserted-by":"crossref","first-page":"831","DOI":"10.3390\/pharmaceutics14040831","article-title":"Fundamental Aspects of Lipid-based Excipients in Lipid-based Product Development","volume":"14","author":"Nakmode","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejpb.2025.114964_b0025","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2019.01196","article-title":"Physiological and pharmaceutical considerations for rectal drug formulations","volume":"10","author":"Hua","year":"2019","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejpb.2025.114964_b0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2025.114938","article-title":"Investigating the behaviour of lipid nanoparticles upon meeting biological barriers in colorectal drug delivery","author":"Montasseri","year":"2025","journal-title":"Colloids Surf B Biointerfaces 255"},{"key":"10.1016\/j.ejpb.2025.114964_b0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/biomedicines8120563","article-title":"3D printed tacrolimus rectal formulations ameliorate colitis in an experimental animal model of inflammatory bowel disease","volume":"8","author":"Seoane-Via\u00f1o","year":"2020","journal-title":"Biomedicines"},{"key":"10.1016\/j.ejpb.2025.114964_b0040","first-page":"110","article-title":"3D printed tacrolimus suppositories for the treatment of ulcerative colitis, asian","volume":"16","author":"Seoane-Via\u00f1o","year":"2021","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2025.114964_b0045","article-title":"3D printing of patient-tailored SNEDDS-based suppositories of lidocaine","volume":"61","author":"Chatzitaki","year":"2021","journal-title":"J Drug Deliv Sci Technol"},{"key":"10.1016\/j.ejpb.2025.114964_b0050","article-title":"3D printed multi-drug-loaded suppositories for acute severe ulcerative colitis","volume":"5","author":"Awad","year":"2023","journal-title":"Int J Pharm X"},{"key":"10.1016\/j.ejpb.2025.114964_b0055","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.ejpb.2020.04.027","article-title":"Novel approach for overcoming the stability challenges of lipid-based excipients. Part 3: Application of polyglycerol esters of fatty acids for the next generation of solid lipid nanoparticles","author":"Corzo","year":"2020","journal-title":"European Journal of Pharmaceutics and Biopharmaceutics 152"},{"key":"10.1016\/j.ejpb.2025.114964_b0060","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.ejpb.2020.01.009","article-title":"Novel approach for overcoming the stability challenges of lipid-based excipients. Part 2: Application of polyglycerol esters of fatty acids as hot melt coating excipients","author":"Salar-Behzadi","year":"2020","journal-title":"European Journal of Pharmaceutics and Biopharmaceutics 148"},{"key":"10.1016\/j.ejpb.2025.114964_b0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.121259","article-title":"Lipid-microparticles for pulmonary delivery of active pharmaceutical ingredients: Impact of lipid crystallization on spray-drying processability","author":"Corzo","year":"2021","journal-title":"Int J Pharm 610"},{"key":"10.1016\/j.ejpb.2025.114964_b0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2023.123201","article-title":"Lipid-based particle engineering via spray-drying for targeted delivery of antibiotics to the lung","author":"Corzo","year":"2023","journal-title":"Int J Pharm 642"},{"key":"10.1016\/j.ejpb.2025.114964_b0075","doi-asserted-by":"crossref","first-page":"277","DOI":"10.4155\/tde.14.3","article-title":"The PulmoSphereTM Platform for Pulmonary Drug delivery","volume":"5","author":"Weers","year":"2014","journal-title":"Ther. Deliv."},{"key":"10.1016\/j.ejpb.2025.114964_b0080","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.ijpharm.2015.11.039","article-title":"Advanced stable lipid-based formulations for a patient-centric product design","volume":"497","author":"Becker","year":"2016","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2025.114964_b0085","doi-asserted-by":"crossref","DOI":"10.1016\/S0928-0987(00)00167-6","article-title":"Lipid formulations for oral administration of drugs: Non-emulsifying, self-emulsifying and \u201cself-microemulsifying\u201d drug delivery systems","volume":"11","author":"Pouton","year":"2000","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2025.114964_b0090","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.ejps.2006.04.016","article-title":"Formulation of poorly water-soluble drugs for oral administration: physicochemical and physiological issues and the lipid formulation classification system","volume":"29","author":"Pouton","year":"2006","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2025.114964_b0095","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.addr.2007.10.010","article-title":"Formulation of lipid-based delivery systems for oral administration: materials, methods and strategies","volume":"60","author":"Pouton","year":"2008","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejpb.2025.114964_b0100","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.addr.2016.04.007","article-title":"50years of oral lipid-based formulations: Provenance, progress and future perspectives","volume":"101","author":"Feeney","year":"2016","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejpb.2025.114964_b0105","doi-asserted-by":"crossref","first-page":"e97","DOI":"10.1016\/j.ddtec.2012.03.002","article-title":"Lipid-based formulations for oral delivery of lipophilic drugs","volume":"9","author":"Kuentz","year":"2012","journal-title":"Drug Discov. Today Technol."},{"key":"10.1016\/j.ejpb.2025.114964_b0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2025.126018","article-title":"Decoding excipients in lipid-based self-emulsifying drug delivery systems: Insights into physicochemical properties and therapeutic outcomes","author":"Silva-Neto","year":"2025","journal-title":"Int J Pharm 683"},{"key":"10.1016\/j.ejpb.2025.114964_b0115","doi-asserted-by":"crossref","unstructured":"X. Hou, T. Zaks, R. Langer, Y. Dong, Lipid nanoparticles for mRNA delivery, Nature Reviews Materials 2021 6:12 6 (2021) 1078\u20131094. https:\/\/doi.org\/10.1038\/s41578-021-00358-0.","DOI":"10.1038\/s41578-021-00358-0"},{"key":"10.1016\/j.ejpb.2025.114964_b0120","first-page":"517","article-title":"3D Printing","volume":"47","author":"Bechtold","year":"2016","journal-title":"Intellectual Property and Innovation Policy, International Review of Intellectual Property and Competition Law"},{"key":"10.1016\/j.ejpb.2025.114964_b0125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/17425247.2017.1371698","article-title":"3D printing of oral drugs: a new reality or hype?","volume":"15","author":"Hsiao","year":"2018","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.ejpb.2025.114964_b0130","unstructured":"Aprecia, FDA Approves Spritam (levetiracetam) as the First 3D Printed Drug Product. https:\/\/www.drugs.com\/newdrugs\/fda-approves-spritam-levetiracetam-first-3d-printed-product-4240.html, (n.d.). https:\/\/www.drugs.com\/newdrugs\/fda-approves-spritam-levetiracetam-first-3d-printed-product-4240.html (accessed 4 January 2024) (accessed January 4, 2024)."},{"key":"10.1016\/j.ejpb.2025.114964_b0135","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.3390\/ph16111521","article-title":"A Bibliometric Analysis of 3D Printing in Personalized Medicine Research from 2012 to 2022","volume":"16","author":"Xue","year":"2023","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.ejpb.2025.114964_b0140","doi-asserted-by":"crossref","unstructured":"S.J. Trenfield, C.M. Madla, A.W. Basit, S. Gaisford, The Shape of Things to Come: Emerging Applications of 3D Printing in Healthcare, in: A.W. Basit, S. Gaisford (Eds.), 3D Printing of Pharmaceuticals, Springer, Cham, 2018: pp. 1\u201319. https:\/\/doi.org\/10.1007\/978-3-319-90755-0_1.","DOI":"10.1007\/978-3-319-90755-0_1"},{"key":"10.1016\/j.ejpb.2025.114964_b0145","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1007\/s11095-018-2454-x","article-title":"3D Printing in Pharmaceutical and Medical applications \u2013 recent Achievements and challenges","volume":"35","author":"Jamr\u00f3z","year":"2018","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2025.114964_b0150","doi-asserted-by":"crossref","DOI":"10.1088\/1757-899X\/280\/1\/012033","article-title":"From GCode to STL: Reconstruct Models from 3D Printing as a Service","volume":"280","author":"Baumann","year":"2017","journal-title":"IOP Conf. Ser.: Mater. Sci. Eng."},{"key":"10.1016\/j.ejpb.2025.114964_b0155","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.ejps.2019.05.008","article-title":"Digital light processing (DLP)3D-printing technology and photoreactive polymers in fabrication of modified-release tablets","volume":"135","author":"Kadry","year":"2019","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2025.114964_b0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.120639","article-title":"Melt extrusion deposition (MED TM) 3D printing technology \u2013 a paradigm shift in design and development of modified release drug products","volume":"602","author":"Zheng","year":"2021","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2025.114964_b0165","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics14081732","article-title":"Innovations in Chewable Formulations: the Novelty and applications of 3D Printing in Drug Product Design","volume":"14","author":"Rodr\u00edguez-Pombo","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejpb.2025.114964_b0170","article-title":"Application of 3D Printing in Implantable Medical Devices","volume":"2021","author":"Wang","year":"2021","journal-title":"Biomed Res. Int."},{"key":"10.1016\/j.ejpb.2025.114964_b0175","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics14122693","article-title":"A Review of 3D-printing of Microneedles","volume":"14","author":"Olowe","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejpb.2025.114964_b0180","doi-asserted-by":"crossref","unstructured":"I.I. Andreadis, C.I. Gioumouxouzis, G.K. Eleftheriadis, D.G. Fatouros, Correction: Andreadis et al. The Advent of a New Era in Digital Healthcare: A Role for 3D Printing Technologies in Drug Manufacturing? Pharmaceutics2022, 14, 609, Pharmaceutics 14 (2022). https:\/\/doi.org\/10.3390\/PHARMACEUTICS14122782.","DOI":"10.3390\/pharmaceutics14122782"},{"key":"10.1016\/j.ejpb.2025.114964_b0185","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics15071877","article-title":"Practical Application of 3D Printing for Pharmaceuticals in Hospitals and Pharmacies","volume":"15","author":"Huanbutta","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejpb.2025.114964_b0190","article-title":"3D Printing in a hospital: Centralized clinical implementation and applications for comprehensive care","volume":"9","author":"Hellman","year":"2023","journal-title":"Digit Health"},{"key":"10.1016\/j.ejpb.2025.114964_b0195","doi-asserted-by":"crossref","unstructured":"A.A. Mohammed, M.S. Algahtani, M.Z. Ahmad, J. Ahmad, S. Kotta, 3D Printing in medicine: Technology overview and drug delivery applications, Annals of 3D Printed Medicine 4 (2021) 100037. https:\/\/doi.org\/10.1016\/J.STLM.2021.100037.","DOI":"10.1016\/j.stlm.2021.100037"},{"key":"10.1016\/j.ejpb.2025.114964_b0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2022.122480","article-title":"3D printing: innovative solutions for patients and pharmaceutical industry","volume":"631","author":"Tracy","year":"2023","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2025.114964_b0205","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1080\/03639045.2017.1342654","article-title":"Review and analysis of FDA approved drugs using lipid-based formulations","volume":"43","author":"Savla","year":"2017","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.ejpb.2025.114964_b0210","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jconrel.2014.06.004","article-title":"Solid lipid excipients - matrix agents for sustained drug delivery","volume":"188","author":"Rosiaux","year":"2014","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2025.114964_b0215","first-page":"239","author":"O\u2019Keefe","year":"2010","journal-title":"Fat Characterization"},{"key":"10.1016\/j.ejpb.2025.114964_b0220","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1016\/S0009-2509(00)00458-9","article-title":"Crystallization behaviour of fats and lipids \u2014 a review","volume":"56","author":"Sato","year":"2001","journal-title":"Chem. Eng. Sci."},{"key":"10.1016\/j.ejpb.2025.114964_b0225","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1111\/j.2042-7158.2010.01107.x","article-title":"New perspectives on lipid and surfactant based drug delivery systems for oral delivery of poorly soluble drugs","volume":"62","author":"M\u00fcllertz","year":"2010","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.ejpb.2025.114964_b0230","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.ijpharm.2013.03.054","article-title":"Lipid-based formulations for oral administration of poorly water-soluble drugs","author":"Mu","year":"2013","journal-title":"Int J Pharm 453"},{"key":"10.1016\/j.ejpb.2025.114964_b0235","doi-asserted-by":"crossref","unstructured":"C.J.H. Porter, N.L. Trevaskis, W.N. Charman, Lipids and lipid-based formulations: optimizing the oral delivery of lipophilic drugs, Nature Reviews Drug Discovery 2007 6:3 6 (2007) 231\u2013248. https:\/\/doi.org\/10.1038\/nrd2197.","DOI":"10.1038\/nrd2197"},{"key":"10.1016\/j.ejpb.2025.114964_b0240","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1111\/j.2042-7158.2010.01030.x","article-title":"Pharmaceutical applications of cyclodextrins: basic science and product development","volume":"62","author":"Loftsson","year":"2010","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.ejpb.2025.114964_b0245","article-title":"The Innovator Pipeline\u00a0: Bioavailability challenges and Advanced Oral Drug delivery Opportunities","author":"Lipp","year":"2013","journal-title":"Am Pharm Rev"},{"key":"10.1016\/j.ejpb.2025.114964_b0250","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fnut.2021.570401","article-title":"A Brief Journey into the history of and Future sources and Uses of Fatty Acids","volume":"8","author":"Cerone","year":"2021","journal-title":"Front. Nutr."},{"key":"10.1016\/j.ejpb.2025.114964_b0255","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.ijpharm.2016.04.058","article-title":"Taste-masking properties of solid lipid based micropellets obtained by cold extrusion-spheronization","volume":"506","author":"Petrovick","year":"2016","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2025.114964_b0260","doi-asserted-by":"crossref","first-page":"145","DOI":"10.3109\/03639045.2013.804833","article-title":"A review on the taste masking of bitter APIs: Hot-melt extrusion (HME) evaluation","volume":"40","author":"Maniruzzaman","year":"2014","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.ejpb.2025.114964_b0265","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.ejps.2008.08.002","article-title":"Solid lipid extrudates as sustained-release matrices: the effect of surface structure on drug release properties","volume":"35","author":"Reitz","year":"2008","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2025.114964_b0270","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.1016\/j.apsb.2021.05.014","article-title":"Zhou, Pharmaceutical amorphous solid dispersion: a review of manufacturing strategies","volume":"11","author":"Bhujbal","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.ejpb.2025.114964_b0275","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1002\/med.21403","article-title":"Applications of Polymers as Pharmaceutical Excipients in Solid Oral Dosage Forms","volume":"37","author":"Debotton","year":"2017","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.ejpb.2025.114964_b0280","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.jmapro.2018.08.008","article-title":"What makes a material printable? a viscoelastic model for extrusion-based 3D printing of polymers","volume":"35","author":"Duty","year":"2018","journal-title":"J. Manuf. Process."},{"key":"10.1016\/j.ejpb.2025.114964_b0285","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2021.113943","article-title":"Pharmaceutical applications of powder-based binder jet 3D printing process \u2013 a review","volume":"177","author":"Sen","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejpb.2025.114964_b0290","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.jconrel.2020.10.008","article-title":"Vat photopolymerization 3D printing for advanced drug delivery and medical device applications","volume":"329","author":"Xu","year":"2021","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2025.114964_b0295","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202309164","article-title":"Inkjet Printing of Pharmaceuticals","volume":"36","author":"Carou-Senra","year":"2024","journal-title":"Adv. Mater."},{"key":"10.1016\/j.ejpb.2025.114964_b0300","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.jconrel.2021.02.027","article-title":"Semi-solid extrusion 3D printing in drug delivery and biomedicine: Personalised solutions for healthcare challenges","volume":"332","author":"Seoane-Via\u00f1o","year":"2021","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2025.114964_b0305","doi-asserted-by":"crossref","unstructured":"S. Wang, X. Chen, X. Han, X. Hong, X. Li, H. Zhang, M. Li, Z. Wang, A. Zheng, A Review of 3D Printing Technology in Pharmaceutics: Technology and Applications, Now and Future, Pharmaceutics 2023, Vol. 15, Page 416 15 (2023) 416. https:\/\/doi.org\/10.3390\/PHARMACEUTICS15020416.","DOI":"10.3390\/pharmaceutics15020416"},{"key":"10.1016\/j.ejpb.2025.114964_b0310","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1002\/ejlt.201500410","article-title":"Viscosity\u2013temperature relationship of lipid-based excipients amenable for spray congealing: Derivation of a rheological parameter with good correlation to particle size","volume":"118","author":"Wong","year":"2016","journal-title":"Eur. J. Lipid Sci. Technol."},{"key":"10.1016\/j.ejpb.2025.114964_b0315","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.ijpharm.2017.04.003","article-title":"Dropwise additive manufacturing of pharmaceutical products for amorphous and self emulsifying drug delivery systems","volume":"524","author":"I\u00e7ten","year":"2017","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2025.114964_b0320","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.jconrel.2017.06.025","article-title":"3D inkjet printing of tablets exploiting bespoke complex geometries for controlled and tuneable drug release","volume":"261","author":"Kyobula","year":"2017","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2025.114964_b0325","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.3390\/pharmaceutics13101679","article-title":"Customisable tablet printing: the development of multimaterial hot melt inkjet 3D printing to produce complex and personalised dosage forms","volume":"13","author":"Lion","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejpb.2025.114964_b0330","first-page":"1567","article-title":"3D printing injectable microbeads using a composite liposomal ink for local treatment of peritoneal diseases, Drug Deliv","volume":"14","author":"Eugster","year":"2024","journal-title":"Transl. Res."},{"key":"10.1016\/j.ejpb.2025.114964_b0335","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1007\/s11095-019-2639-y","article-title":"A Proof of Concept for 3D Printing of Solid Lipid-based Formulations of Poorly Water-Soluble Drugs to Control Formulation Dispersion Kinetics","volume":"36","author":"Vithani","year":"2019","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2025.114964_b0340","doi-asserted-by":"crossref","DOI":"10.1016\/j.foodres.2019.108676","article-title":"Extrusion 3D printing of nutraceutical oral dosage forms formulated with monoglycerides oleogels and phytosterols mixtures","volume":"126","author":"Cotabarren","year":"2019","journal-title":"Food Res. Int."},{"key":"10.1016\/j.ejpb.2025.114964_b0345","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2020.119298","article-title":"Partial tablet coating by 3D printing","volume":"581","author":"Tsintavi","year":"2020","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2025.114964_b0350","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2020.105291","article-title":"Pediatric-friendly chocolate-based dosage forms for the oral administration of both hydrophilic and lipophilic drugs fabricated with extrusion-based 3D printing","volume":"147","author":"Karavasili","year":"2020","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2025.114964_b0355","doi-asserted-by":"crossref","DOI":"10.1016\/j.lwt.2025.117320","article-title":"Relationship between physicochemical properties of roasted cocoa beans and climate patterns: Quality and safety implications","volume":"216","author":"Betancourt-Sambony","year":"2025","journal-title":"LWT"},{"key":"10.1016\/j.ejpb.2025.114964_b0360","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.neubiorev.2009.01.001","article-title":"Caffeine Use in Children: what we know, what we have left to learn, and why we should worry","volume":"33","author":"Temple","year":"2009","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.ejpb.2025.114964_b0365","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.120304","article-title":"3D-printing of solid lipid tablets from emulsion gels","volume":"597","author":"Johannesson","year":"2021","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2025.114964_b0370","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1016\/j.jcis.2023.07.055","article-title":"Synergistic stabilization of emulsion gel by nanoparticles and surfactant enables 3D printing of lipid-rich solid oral dosage forms","volume":"650","author":"Johannesson","year":"2023","journal-title":"J. Colloid Interface Sci."},{"key":"10.1016\/j.ejpb.2025.114964_b0375","first-page":"984","article-title":"Combining the potential of 3D printed buccal films and nanostructured lipid carriers for personalised cannabidiol delivery, Drug Deliv","volume":"14","author":"Abdella","year":"2024","journal-title":"Transl. Res."},{"key":"10.1016\/j.ejpb.2025.114964_b0380","doi-asserted-by":"crossref","DOI":"10.1002\/admt.202301930","article-title":"3D-printed Lipid Mesophases for the Treatment of Chronic Liver Disease","volume":"9","author":"Carone","year":"2024","journal-title":"Adv. Mater. Technol."},{"key":"10.1016\/j.ejpb.2025.114964_b0385","unstructured":"Triastek announces research collaboration and platform technology license agreement with BioNTech to Advance 3D Printed Oral RNA Therapeutics-News-\u4e09\u8fed\u7eaa TRIASTEK, (n.d.). https:\/\/www.triastek.com\/detail\/36.html%20access%20September%202025 (accessed September 30, 2025)."},{"key":"10.1016\/j.ejpb.2025.114964_b0390","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.3390\/pharmaceutics13122107","article-title":"A 3D-printed Polymer \u2013 Lipid-Hybrid Tablet towards the Development of Bespoke SMEDDS Formulations","volume":"13","author":"Barber","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejpb.2025.114964_b0395","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioadv.2022.212818","article-title":"Extrusion and 3D printing of novel lipid-polymer blends for oral drug applications","volume":"137","author":"Tang","year":"2022","journal-title":"Biomaterials Advances"},{"key":"10.1016\/j.ejpb.2025.114964_b0400","article-title":"Personalization of lipid-based oral dosage forms via filament-based 3D-printing","volume":"40","author":"Abdelhamid","year":"2024","journal-title":"Appl. Mater. Today"},{"key":"10.1016\/j.ejpb.2025.114964_b0405","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2022.122013","article-title":"Filament-based 3D-printing of placebo dosage forms using brittle lipid-based excipients","volume":"624","author":"Abdelhamid","year":"2022","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2025.114964_b0410","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2023.123279","article-title":"Mechanically promoted lipid-based filaments via composition tuning for extrusion-based 3D-printing","volume":"643","author":"Abdelhamid","year":"2023","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2025.114964_b0415","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.ijpharm.2019.05.036","article-title":"Correlation between the solid state of lipid coating and release profile of API from hot melt coated microcapsules","volume":"565","author":"Salar-Behzadi","year":"2019","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2025.114964_b0420","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1007\/s11095-018-2531-1","article-title":"An Overview of 3D Printing Technologies for Soft Materials and Potential Opportunities for Lipid-based Drug delivery Systems","volume":"36","author":"Vithani","year":"2019","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2025.114964_b0425","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.ejpb.2020.01.012","article-title":"Novel approach for overcoming the stability challenges of lipid-based excipients. Part 1: Screening of solid-state and physical properties of polyglycerol esters of fatty acids as advanced pharmaceutical excipients","author":"Corzo","year":"2020","journal-title":"European Journal of Pharmaceutics and Biopharmaceutics 148"},{"key":"10.1016\/j.ejpb.2025.114964_b0430","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0927-7765(00)00175-2","article-title":"Effects of addition of hydrophobic sucrose fatty acid oligoesters on crystallization rates of n-hexadecane in oil-in-water emulsions","volume":"20","author":"Katsuragi","year":"2001","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"10.1016\/j.ejpb.2025.114964_b0435","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1021\/cg034136v","article-title":"Effects of Glycerol and Tween 60 on the Crystallization Behavior, Mechanical Properties, and Microstructure of a Plastic Fat","volume":"4","author":"Litwinenko","year":"2004","journal-title":"Cryst. Growth Des."},{"key":"10.1016\/j.ejpb.2025.114964_b0440","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.colsurfb.2004.05.017","article-title":"Influences of fatty acid moiety and esterification of polyglycerol fatty acid esters on the crystallization of palm mid fraction in oil-in-water emulsion","volume":"37","author":"Sakamoto","year":"2004","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"10.1016\/j.ejpb.2025.114964_b0445","unstructured":"G\u00dcNTHER Hot Runner Technology, Valve gate nozzles. https:\/\/www.guenther-hotrunner.com\/products\/hot-runner-systems\/valve-gate-systems\/valve-gate-nozzles.html, (n.d.). https:\/\/www.guenther-hotrunner.com\/products\/hot-runner-systems\/valve-gate-systems\/valve-gate-nozzles.html."},{"key":"10.1016\/j.ejpb.2025.114964_b0450","article-title":"Integration of a needle valve mechanism with cura slicing software for improved retraction in pellet-based material extrusion","volume":"82","author":"Morita","year":"2024","journal-title":"Addit. Manuf."},{"key":"10.1016\/j.ejpb.2025.114964_b0455","unstructured":"INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE ICH HARMONISED TRIPARTITE GUIDELINE STABILITY TESTING OF NEW DRUG SUBSTANCES AND PRODUCTS Q1A(R2), (2003)."},{"key":"10.1016\/j.ejpb.2025.114964_b0460","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/j.addr.2007.09.010","article-title":"Lipid excipients and delivery systems for pharmaceutical development: a regulatory perspective","volume":"60","author":"Chen","year":"2008","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejpb.2025.114964_b0465","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.ijpharm.2018.05.048","article-title":"Novel excipients - Regulatory challenges and perspectives - the EU insight","volume":"546","author":"Kozarewicz","year":"2018","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2025.114964_b0470","unstructured":"Nonclinical Studies for the Safety Evaluation of Pharmaceutical Excipients | FDA, (n.d.). https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/nonclinical-studies-safety-evaluation-pharmaceutical-excipients (accessed September 30, 2025)."},{"key":"10.1016\/j.ejpb.2025.114964_b0475","article-title":"Towards predicting the product quality in hot-melt extrusion: small scale extrusion","volume":"2","author":"Mati\u0107","year":"2020","journal-title":"Int J Pharm X"},{"key":"10.1016\/j.ejpb.2025.114964_b0480","article-title":"Towards predicting the product quality in hot-melt extrusion: pilot plant scale extrusion","volume":"3","author":"Mati\u0107","year":"2021","journal-title":"Int J Pharm X"},{"key":"10.1016\/j.ejpb.2025.114964_b0485","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.ejpb.2019.07.009","article-title":"Scale-up of pharmaceutical Hot-Melt-Extrusion: Process optimization and transfer","volume":"142","author":"Wesholowski","year":"2019","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2025.114964_b0490","doi-asserted-by":"crossref","DOI":"10.1016\/j.apt.2023.104166","article-title":"Analysis of powder behaviour in bin blending processes at different scales using DEM","volume":"34","author":"Mostafaei","year":"2023","journal-title":"Adv. Powder Technol."},{"key":"10.1016\/j.ejpb.2025.114964_b0495","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.powtec.2015.01.049","article-title":"Macro- and micro-mixing of a cohesive pharmaceutical powder during scale up","volume":"274","author":"Shi","year":"2015","journal-title":"Powder Technol."}],"container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S093964112500342X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S093964112500342X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T13:13:02Z","timestamp":1773925982000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S093964112500342X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":99,"alternative-id":["S093964112500342X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpb.2025.114964","relation":{},"ISSN":["0939-6411"],"issn-type":[{"value":"0939-6411","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"3D-printing of lipid formulations: Going slow in a fast-paced field","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutics and Biopharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpb.2025.114964","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"114964"}}